Gujarat Inject P/E Ratio
Current P/E Ratio
153.14
High Valuation
Very High - High growth expectations or significantly overvalued
Gujarat Inject (GUJINJEC) P/E ratio is 153.14 (High), EPS (TTM) ₹0.70, current price ₹107.20 on BSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see GUJINJEC screener.
Current Valuation Metrics
P/E Ratio
153.14
Current Price
₹107.20
EPS (TTM)
₹0.70
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
50.08
Sector Median
28.75
Sector Rank
#11 of 191
Sector Percentile
5.8%
GUJINJEC P/E Ratio — Valuation Signal & Historical Context
Gujarat Inject P/E 153.14 — signal: Overvalued. Browse GUJINJEC balance sheet details for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PE of 153.14, suggesting caution for new investments
- Trading at premium to sector average PE of 50.08
GUJINJEC vs Healthcare Peers — P/E Ratio Comparison
Gujarat Inject P/E 153.14 vs Healthcare average 50.08, median 28.75 — range 0.97–869.57.
Sector Average
50.08
Sector Median
28.75
Lowest P/E
0.97
Highest P/E
869.57
Companies
191
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |